Systematic review of the use of translated patient-reported outcome measures in cancer trials

BACKGROUND: Patient-reported outcomes (PROs) are used in clinical trials to assess the effectiveness and tolerability of interventions. Inclusion of participants from different ethnic backgrounds is essential for generalisability of cancer trial results. PRO data collection should include appropriat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Trials
Auteurs principaux: Slade, A. L., Retzer, A., Ahmed, K., Kyte, D., Keeley, T., Armes, J., Brown, J. M., Calman, L., Gavin, A., Glaser, A. W., Greenfield, D. M., Lanceley, A., Taylor, R. M., Velikova, G., Turner, G., Calvert, M. J.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8074490/
https://ncbi.nlm.nih.gov/pubmed/33902699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-021-05255-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires